Homepage | Medicines Discovery Catapult

Innovation in medicine discovery science, to more rapidly benefit patients, lies at the heart of the strategy for the Medicines Discovery Catapult

The many ways charities can boost innovation in medical research

Among the wealth and diversity of stakeholders that bring science out of the laboratories and closer to patients, charities are usually regarded as the hands-off funders of research. However, an increasing number of biomedical research charities have been taking a more proactive and involved role in boosting innovation in the therapeutic areas they support. Action […]

International Women’s Day – 5 questions with Dr Gemma Holliday

1. What challenges have you faced, as a woman, entering this industry? The biggest by far is Imposter Syndrome, I think most people will suffer from this at some point in their lives (and I don’t just mean women!). It’s not an easy one to overcome either – and the only advice I can offer […]

New methods to improve the translation of biomedical science towards clinical trial success

It is now over ten years since John Ioannidis published his essay on ‘Why most published findings are false’. This paper presented statistical arguments to remind the research community that a finding is less likely to be true if: 1) study size is small, 2) effect size is small, 3) a protocol is not pre-determined […]

The (re)emergence of an Oncology drug discovery ecosystem

Attending the recent BioNow Oncology event at Alderley Park, I was struck by the strength of an Oncology drug discovery interdisciplinary community in the North West, which hardly existed at all a few years ago. Or, perhaps more accurately, did exist but was hidden behind the tall walls of Pharma. Many ex-AstraZeneca scientists have emerged […]

"Putting the voice of patients at the heart of drug discovery is vital to develop the new targeted therapies of the future."

Chris Molloy, Chief Executive Officer

It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn

At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.

Partnership opportunities

Our position as an impartial not-for-profit organisation means we are uniquely placed to bring groups together from the private, public, academic and charitable sectors. We are able to offer these groups the facilities, expertise and tools that will ultimately make a real difference to the lives of patients. Organisations can also partner with us to help resolve particular short-term bottlenecks or problems including poor access to data and samples.

Find out more

We're recruiting

We’re now looking for talented scientists and technologists to join the Medicines Discovery Catapult team to help keep the UK at the forefront of medicines discovery. If you share our values and have the skills, drive and resilience to be part of an organisation looking to move the UK’s life sciences sector forward faster, we would be delighted to hear from you.

View our vacancies

Science & Technology

Informatics

Virtual R&D

Discovery Syndicates

Samples and Data